Abstract:Peroxiredoxins (Prxs) are a ubiquitously expressed family of antioxidant enzymes that either facilitate or inhibit tumorigenesis, depending on the cancer type and Prx isoform. Prx2 is a typical Prx that has a dual role in tumorigenesis and tumor progression. However, the expression of Prx2 and its precise role in cervical cancer remains to be elucidated. Therefore, the present study aimed to investigate the expression of Prx2 and its association with the progression and prognosis of cervical squamous cell cancer (CSCC). In the present study, the clinicopathological data of 105 patients diagnosed with CSCC were collected from the medical record system at Jingzhou Central Hospital, Tongji Medical College of Huazhong University of Science and Technology (Jingzhou, China). Prx2 protein was also detected in 105 CSCC tissues and 40 adjacent peri‐tumoral tissues by immunohistochemical staining. The relationships between Prx2 expression and clinicopathological features, vascular endothelial growth factor A (VEGF‐A) expression and micro‐vessel density (MVD) in CSCC were then analyzed. Progression‐free survival (PFS) was also assessed using both univariate and multivariate analyses. The results of the present study demonstrated that the expression of Prx2 was upregulated in CSCC tissues compared with the adjacent peri‐tumoral tissues (P 0.05). Furthermore, increased Prx2 expression was associated with high MVD (P=0.016), while expression of VEGF‐A was not associated with Prx2 expression (P>0.05). Kaplan‐Meier analysis showed that patients with high Prx2 expression (log‐rank test, P=0.039), high MVD (log‐rank test, P=0.015), a higher FIGO stage (log‐rank test, P=0.021) and LN metastasis (log‐rank test, P=0.022) had a shorter PFS time than patients with low Prx2 expression, low MVD, a lower FIGO stage and without LN metastasis, respectively. Cox proportional hazard regression analysis revealed that expression of Prx2 [hazard ratio (HR), 2.551; 95% confidence interval (CI), 1.056‐6.162; P=0.037], MVD (HR, 2.436; CI, 1.034‐5.735; P=0.042) and FIGO stage (HR, 1.543; CI, 1.027‐2.319; P=0.037) were independent factors for PFS time. In conclusion, the results of the present study suggested that Prx2 could act as a potential biomarker for predicting CSCC progression and prognosis and could be a novel target for antiangiogenic therapy of CSCC.

[Expression of Peroxiredoxin III in Cervical Lesions].

Nucleotide Excision Repair Gene Subunit Xpd is Highly Expressed in Cervical Squamous Cell Carcinoma

Up-regulation of peroxiredoxin-1 promotes cell proliferation and metastasis and inhibits apoptosis in cervical cancer

[The Expression of Peroxiredoxin II in Hepatocellular Carcinoma and Its Significance].

[Expression of Peroxiredoxin 6 in Gastric Cancer and Its Clinical Significance].

Impact of peroxiredoxin-6 expression on colon adenocarcinoma

The Prognostic Values of the Peroxiredoxins Family in Ovarian Cancer

[The Biological Function of Peroxiredoxin II on Hep3B Cells and Its Underlying Mechanism].

Peroxiredoxin 2 as a potential prognostic biomarker associated with angiogenesis in cervical squamous cell cancer

Peroxiredoxin 3 regulates breast cancer progression via ERK-mediated MMP-1 expression

Altered expression of cellular membrane molecules of HLA-DR, HLA-G and CD99 in cervical intraepithelial neoplasias and invasive squamous cell carcinoma.

Protein Expression Levels Of Excision Repair Cross-Complementation Group 1 And Xeroderma Pigmentosum D Correlate With Response To Platinum-Based Chemotherapy In The Patients With Advanced Epithelial Ovarian Cancer

Negative immune factors might predominate local tumor immune status and promote carcinogenesis in cervical carcinoma

Over-expression of decoy receptor 3 in gastric precancerous lesions and carcinoma.

Assessment of Potential Prognostic Value of Peroxiredoxin 1 in Oral Squamous Cell Carcinoma

Comprehensive Analysis of the PRDXs Family in Head and Neck Squamous Cell Carcinoma

Silencing PRDX3 Inhibits Growth and Promotes Invasion and Extracellular Matrix Degradation in Hepatocellular Carcinoma Cells

Erythroblast transformation‐specific‐related gene promotes metastasis of oral squamous cell carcinoma by transcriptionally upregulating peroxiredoxin 1

Overexpression of Extracellular Superoxide Dismutase 3 Inhibits Cancer Cell Growth and Migration in Colorectal Cancer

Integrative analysis the characterization of peroxiredoxins in pan-cancer

Expression and clinical role of PRDX6 in lung adenocarcinoma